Rekah Pharmaceutical Prod Ltd. Logo

Rekah Pharmaceutical Prod Ltd.

A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.

REKA | TA

Overview

Corporate Details

ISIN(s):
IL0010810096
LEI:
Country:
Israel
Address:
Hamelaha 30, 5881904 Holon
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rekah Pharmaceutical Prod Ltd. is a generic pharmaceuticals manufacturer with over 70 years of industry experience. The company is active across the entire value chain, from research and development to production, marketing, sales, distribution, import, and export. Its portfolio features over 400 registered products, including generic prescription (Rx) and over-the-counter (OTC) drugs, medical devices, dermo-cosmetics, vitamins, and nutritional supplements. Rekah has in-depth expertise in specific therapeutic categories, specializing in the manufacturing of steroidal tablets, antibiotics, and ophthalmic products. The company focuses on expanding its international footprint through strategic collaborations, co-development partnerships, and licensing agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Rekah Pharmaceutical Prod Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Rekah Pharmaceutical Prod Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Rekah Pharmaceutical Prod Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea 222670
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530

Talk to a Data Expert

Have a question? We'll get back to you promptly.